Clinical Trials Directory

Trials / Unknown

UnknownNCT00449306

Physical,Histological,and Genetic Analyses of Lipid-rich Atherosclerotic Plaques

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Lipid-rich atherosclerotic plaques, or "vulnerable plaques" are prone to rupture, causing local intravascular thrombosis, with subsequent grave clinical consequences. Atherosclerotic plaques normally removed during surgery, and peripheral blood samples will be studied to achieve the following objectives: "1" Define histological features of the vulnerable plaque, analyze its physical characteristics, and investigate selected gene expression. "2" Study biomarkers of inflammation in conjunction with the presence of vulnerable plaques. "3" Explore the potential role of infection in atherogenesis.

Conditions

Timeline

Start date
2001-03-01
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2007-03-20
Last updated
2019-07-05

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00449306. Inclusion in this directory is not an endorsement.